Cannabinoid signaling and risk in Huntington's disease
Dysregulated endocannabinoid (eCB) signaling and the loss of cannabinoid receptors (CB1Rs) are important phenotypes of Huntington's disease (HD) but the precise contribution that eCB signaling has at the circuit level is unknown. Using a computational model of spiking neurons, synapses, and eCB...
| Published in: | Frontiers in Computational Neuroscience |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-09-01
|
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fncom.2022.903947/full |